Whitehawk Therapeutics, Inc.

WHWK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012
Assets
Cash & Equivalents $20.3M $1.6M $5.1M $5.3K $6.3K $4.6K
Accounts Receivable — $4.2K — — — —
Inventory — — — — — —
Total Current Assets $20.9M $2.2M — — — $8.1K
Property, Plant & Equipment $107.2K $149.6K — — — —
Goodwill — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — —
Total Assets $21.0M $2.4M $18.5K $5.3K $8.8K $8.1K
Liabilities
Accounts Payable $1.3M $1.1M $3.7K $2.4K $350 $1.9K
Total Current Liabilities $3.6M $14.9M $205.0K $160.3K $133.0K $103.6K
Long-Term Debt — — — — — —
Total Liabilities $3.6M $88.6M $66.6M $160.3K $133.0K $103.6K
Stockholders' Equity
Retained Earnings $-108.6M $-86.2M $-236.5K $-205.0K — —
Total Stockholders' Equity $17.4M $-86.2M $-66.6M $-155.0K $-124.2K $-95.5K
← Newer Page 2 of 2 Older →